How to resolve AdBlock issue? SARATOGA COUNTY — The county reports mostly stable indicators week-to-week related to community level COVID-19 infection, hospitalization and death rate, as per its most recent posting at the end of July.
The state DOH reports the 7-day average positive test percentage in Saratoga County at 10.5%. Statewide, that average is 8.7%, according to data updated on Aug. 1. Self-administered home tests are NOT included in the data.
Overall, and specific to community, the town of Clifton Park – the most highly populated municipality in the county, reports nearly 8,500 confirmed cases of COVID-19 since the start of pandemic case-counting. The city of Saratoga Springs, the county’s second-most populated municipality reports nearly 7,100 confirmed positive cases in all.
There have been 351 cumulative deaths countywide to date, and just under 60% of fully vaccinated county residents have received a first booster vaccination.
For those seeking to find local pharmacies offering vaccines and boosters across all age groups, Saratoga County refers all to: CDC Vaccine Finder at www.vaccines.gov/, and NYS Vaccine Site at covid19vaccine.health.ny.gov/.
Modified Booster
Anticipated
Next Month
Four weeks ago, the FDA announced it was advising manufacturers to develop modified vaccines that add an omicron BA.4/5 spike protein component to the current vaccine composition to create a two component (bivalent) booster vaccine, so that the modified vaccines can potentially be used starting in early to mid-fall 2022.
The FDA subsequently announced it had received assurances from the vaccine manufacturers — Moderna and Pfizer and its German partner, BioNTech — that the reformulated boosters will be ready in September, according to a report this week in the Washington Post. “Those boosters will contain components from the omicron subvariants BA.4 and BA.5 as well as the original formula, which was based on the version of the virus that spread globally in early 2020. The hope is that the bivalent shots will be more effective against a rapidly evolving virus and shield Americans from a potential fall and winter surge,” according to the report.
